Abstract:Jing Wang, 1, &ast Yanxiang Sang, 2, &ast Weijian Chen, 3 Liang Cheng, 2 Wenxiang Du, 2 Hongjie Zhang, 2 Benyan Zheng, 2 Lei Song, 2 Yuan Hu, 2 Xiaopeng Ma 1 1 Department of General Surgery, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, 230001, People's Republic of China; 2 State Key Laboratory of Fire Science, University of Science and Technology of China, Hefei, Anhui, 230006, People's Republic of China; 3 Technology Center, China Tobacco Anhui Industrial Co, Ltd, Hefei, Anhui, 230088, People's Republic of China &astThese authors contributed equally to this work Correspondence: Yuan Hu; Xiaopeng Ma, Email ; Introduction: As an effective alternative choice to traditional mono-therapy, multifunctional nanoplatforms hold great promise for cancer therapy. Based on the strategies of Fenton-like reactions and reactive oxygen species (ROS)-mediated therapy, black phosphorus (BP) nanoplatform BP@Cu 2 O@L-Arg (BCL) co-assembly of cuprous oxide (Cu 2 O) and L-Arginine (L-Arg) nanoparticles was developed and evaluated for synergistic cascade breast cancer therapy. Methods: Cu 2 O particles were generated in situ on the surface of the BP nanosheets, followed by L-Arg incorporation through electrostatic interactions. In vitro ROS/nitric oxide (NO) generation and glutathione (GSH) depletion were evaluated. In vitro and in vivo anti-cancer activity were also assessed. Finally, immune response of BCL under ultrasound was investigated. Results: Cu 2 O was incorporated into BP to exhaust the overexpressed intracellular GSH in cancer cells via the Fenton reaction, thereby decreasing ROS consumption. Apart from being used as biocompatible carriers, BP nanoparticles served as sonosensitizers to produce excessive ROS under ultrasound irradiation. The enhanced ROS accumulation accelerated the oxidation of L-Arg, which further promoted NO generation for gas therapy. In vitro experiments revealed the outstanding therapeutic killing effects of BCL under ultrasound via mechanisms involving GSH deletion and excessive ROS and NO generation. In vivo studies have illustrated that the nanocomplex modified the immune response by promoting macrophage and CD8+ cell infiltration and inhibiting MDSC infiltration. Discussion: BCL nanoparticles exhibited multifunctional characteristics for GSH depletion-induced ROS/NO generation, making a new multitherapy strategy for cascade breast cancer therapy. Keywords: black phosphorus, combination cancer therapy, sonodynamic therapy, chemodynamic therapy, nitric oxide gas therapy High concentrations of toxic reactive oxygen species (ROS) have been widely applied to induce oxidative damage and apoptosis. 1,2 Based on this approach, innovative therapeutic strategies including photodynamic therapy (PDT), 2 sonodynamic therapy (SDT), 3 and chemical dynamic therapy (CDT) 4 have been developed as powerful alternatives for cancer therapy. Owing to the limitations of monotherapy, researchers have focused on synergistic therapies to achieve the effect of 1+1>2. 5 Black phosphorus (BP), a two-dimensional nanomaterial, exhibits excellent light-absorption performance, high photothermal conversion efficiency, biodegradability, and large specific surface area. 6 BP can be gradually degraded into phosphate ions under physiological conditions without biological toxicity. 7 Owing to its multiple outstanding properties, BP has shown great potential in the biomedical field for PTT, PDT, and SDT applications. 8,9 Compared with light-mediated PTT or PDT, SDT and SDT-based combination therapy have the advantages of higher tissue penetration and minimal invasiveness. Thus, SDT is considered of great significance for cancer therapy. 10–12 Numerous studies have confirmed that BP, as a sonosensitizer, can induce ROS generation in cancer therapy, concomitantly inducing stronger immunogenicity. 13–16 Owing to the high proliferative capacity of cancer cells, the tumor microenvironment is characterized by abnormally high concentrations of glutathione (GSH) and hydrogen peroxide (H 2 O 2 ). 17–19 High GSH levels in cancer cells have been known to readily capture ROS in the cellular environment to generate oxidized glutathione disulfide (GSSG), resulting in a compromised effect of ROS therapy. 20–24 Therefore, it is important to enhance the antioxidant GSH consumption to facilitate ROS generation and achieve the de -Abstract Truncated-

ROS-Mediated Selective Killing Effect of Black Phosphorus: Mechanistic Understanding and its Guidance for Safe Biomedical Applications.

Cytotoxicity Induced by Black Phosphorus Nanosheets in Vascular Endothelial Cells Via Oxidative Stress and Apoptosis Activation

In Vitro and in Vivo Toxicity of Black Phosphorus Nanosheets.

Nanoarchitectonics with Two‐Dimensional Black Phosphorus and MnO<sub>2</sub> for Synergistic Photodynamic‐/Radiotherapy Against Cancer through Enhanced Reactive Oxygen Species Activity

Nanoarchitectonics with Two‐Dimensional Black Phosphorus and MnO2 for Synergistic Photodynamic‐/Radiotherapy Against Cancer through Enhanced Reactive Oxygen Species Activity

Black Phosphorus Nanosheets Induced Oxidative Stress In Vitro and Targeted Photo-thermal Antitumor Therapy

Biodegradable Black Phosphorus-based Nanomaterials in Biomedicine: Theranostic Applications

Black Phosphorus: Black Phosphorus Nanosheets As a Robust Delivery Platform for Cancer Theranostics (adv. Mater. 1/2017)

Inflammatory Response Induced by Black Phosphorus Nanosheets in Mice and Macrophages

Intrinsic bioactivity of black phosphorus nanomaterials on mitotic centrosome destabilization through suppression of PLK1 kinase

Coordination-Driven Enhancement of Radiosensitization by Black Phosphorus via Regulating Tumor Metabolism

Black Phosphorus Quantum Dot Induced Oxidative Stress and Toxicity in Living Cells and Mice

Black Phosphorus, an Emerging Versatile Nanoplatform for Cancer Immunotherapy

Black Phosphorus Nanosheet Encapsulated by Zeolitic Imidazole Framework-8 for Tumor Multimodal Treatments

Bioactive phospho-therapy with black phosphorus for <i>in vivo</i> tumor suppression

Bioactive phospho-therapy with black phosphorus for in vivo tumor suppression

Glutathione Depletion-Induced ROS/NO Generation for Cascade Breast Cancer Therapy and Enhanced Anti-Tumor Immune Response

Stable Black Phosphorus/bi2o3 Heterostructures for Synergistic Cancer Radiotherapy.

Nano-Black Phosphorus for Combined Cancer Phototherapy: Recent Advances and Prospects.

A Highly Effective Π–π Stacking Strategy to Modify Black Phosphorus with Aromatic Molecules for Cancer Theranostics

Stable Black Phosphorus Nanosheets Exhibiting High Tumor-Accumulating and Mitochondria-Targeting for Efficient Photothermal Therapy Via Double Functionalization.